 Chronic treatment enhanced neuroprotective microglia, reduced neuronal damage, tempered microglial inflammatory response and contained toxic beta amyloid plaques in a mouse model of Alzheimers disease. The paper, Anti-human TREM2 antibody induces microglia proliferation and reduces pathology in an Alzheimers Disease model, was carried out in collaboration with Marco Colonna, M.D. at Washington University in St. Louis and can be accessed here. 